Loading…
Lobbying Spend
—
Filings
12
Firms Hired
1
Active Period
2021–2023
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Consolidated Appropriations Act, 2023
2022 · fourth_quarter · Firm: CROSSROADS STRATEGIES, LLC
Legislative and regulatory issues impacting the development of therapies to modulate the immune system; S.3799, PREVENT Pandemics Act; FY2023 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.8295, S.4659); FY2023 Consolidated Appropriations Act (H.R.2617).
Client expense: — · Firm income: $60,000
Matched citations: H.R.2617
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2023
2022 · fourth_quarter · Firm: CROSSROADS STRATEGIES, LLC
Legislative and regulatory issues impacting the development of therapies to modulate the immune system; S.3799, PREVENT Pandemics Act; FY2023 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.8295, S.4659); FY2023 Consolidated Appropriations Act (H.R.2617).
Client expense: — · Firm income: $60,000
Matched citations: H.R.8295
Legislative and regulatory issues impacting the development of therapies to modulate the immune system; S.3799, PREVENT Pandemics Act; FY2023 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.8295, S.4659); FY2023 Consolidated Appropriations Act (H.R.2617).
Client expense: — · Firm income: $60,000
Matched citations: S.3799
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2023
2022 · fourth_quarter · Firm: CROSSROADS STRATEGIES, LLC
Legislative and regulatory issues impacting the development of therapies to modulate the immune system; S.3799, PREVENT Pandemics Act; FY2023 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.8295, S.4659); FY2023 Consolidated Appropriations Act (H.R.2617).
Client expense: — · Firm income: $60,000
Matched citations: S.4659
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2023
2022 · third_quarter · Firm: CROSSROADS STRATEGIES, LLC
Legislative and regulatory issues impacting the development of therapies to modulate the immune system, including COVID-19 and other vaccine programs; S.3799, PREVENT Pandemics Act; FY2023 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.8295, S.4659).
Client expense: — · Firm income: $60,000
Matched citations: H.R.8295
Legislative and regulatory issues impacting the development of therapies to modulate the immune system, including COVID-19 and other vaccine programs; S.3799, PREVENT Pandemics Act; FY2023 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.8295, S.4659).
Client expense: — · Firm income: $60,000
Matched citations: S.3799
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2023
2022 · third_quarter · Firm: CROSSROADS STRATEGIES, LLC
Legislative and regulatory issues impacting the development of therapies to modulate the immune system, including COVID-19 and other vaccine programs; S.3799, PREVENT Pandemics Act; FY2023 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.8295, S.4659).
Client expense: — · Firm income: $60,000
Matched citations: S.4659
Legislative and regulatory issues impacting the development of therapies to modulate the immune system, including COVID-19 and other vaccine programs; S.3799, PREVENT Pandemics Act; FY2023 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations.
Client expense: — · Firm income: $60,000
Matched citations: S.3799
Legislative and regulatory issues impacting the development of therapies to modulate the immune system, including COVID-19 and other vaccine programs; S.3799, PREVENT Pandemics Act.
Client expense: — · Firm income: $60,000
Matched citations: S.3799
Source: Senate LDA